Statewide Standing Order for Pharmacy Naloxone Dispensing

On June 1, 2017, Dr. Howard Haft, DHMH Deputy Secretary for Public Health Services, issued a new statewide standing order allowing Maryland-licensed pharmacists to dispense naloxone to anyone who may be at risk for opioid overdose or in a position to assist someone believed to be experiencing opioid overdose. A person-specific paper or electronic prescription is not required for a pharmacist to dispense naloxone under the standing order. 

The new statewide standing order replaces Dr. Haft’s original order issued December 14, 2015, which authorized pharmacists to dispense naloxone to individuals who had been trained and certified under the Maryland Overdose Response Program (ORP). On May 25, 2017, Governor Hogan signed into law the Heroin and Opioid Prevention Effort (HOPE) and Treatment Act of 2017, which simplifies the process for obtaining naloxone from a pharmacy. As authorized by this law, the new standing order allows pharmacists to dispense naloxone to anyone regardless of whether the person has previously been certified under ORP or received any training in opioid overdose response.

NOTE: The statewide standing order acts only as a prescription for naloxone and does not cover payment to a pharmacy for the medication or supplies needed for its use.  ​

Statewide Standing Order Resources 

1.Dr. Howard Haft Statewide Naloxone Standing Order​ - This is the official standing order document. Pharmacies may request a faxed copy by sending an email to dhmh.naloxone@maryland.gov.

NOTE: The standing order, along with additional documentation, was faxed to pharmacies that have a   Maryland State Controlled Dangerous Substance registration on June 1, 2017.

2.Statewide Naloxone Standing Order: Guidance for Pharmacists​ – This document provides detailed guidance and instructions for pharmacists when dispensing under the standing order.

3.Intranasal Naloxone Overdose Response Brochure​ – A brochure created by the Maryland Overdose Response Program that includes steps for responding to an opioid overdose with intranasal naloxone (2mg/0.4mL NARCAN Nasal Spray).

4.Pharmacies Stocking Naloxone ​(updated 12/19/2016) – The pharmacies on this list have been identified as currently stocking naloxone by the pharmacies’ business or corporate offices. 

NOTE: DHMH has not independently verified the accuracy of this information. Individuals are encouraged to call the pharmacy and speak with a pharmacist about naloxone availability and dispensing under the statewide standing order.

Resources for Pharmacists and Patients

Pharmacists are encouraged to offer counseling and instruction to individuals being dispensed naloxone under the statewide standing order on how to recognize the signs and symptoms of an opioid overdose, the importance of contacting emergency medical services, proper administration of naloxone and other appropriate topics. 

Please visit the Guidance and Resources ​section for educational resources for prescribers, pharmacists and patients. ​
​​